Managing a mavacamten non-responder in obstructive hypertrophic cardiomyopathy: A case report. (PubMed, J Cardiol Cases) - Oct 18, 2026 - "It highlights the need for careful evaluation of concomitant mitral valve pathology, which may significantly contribute to persistent symptoms beside left ventricular outflow tract obstruction. In selected patients, timely consideration of surgical intervention remains essential to achieve optimal hemodynamic improvement and symptomatic relief when pharmacological treatment alone is insufficient."
Journal • Cardiomyopathy • Cardiovascular • Fibrosis • Hypertrophic Cardiomyopathy • Immunology • Obstructive Hypertrophic Cardiomyopathy • MYH7
|
|
Felix Langkamp; Jan Michael Federspiel; Smita Scholtz; Vasco Sequeira; Volker Rudolph
|